
Research Team
Christina Silcox, PhD
Contact
Focus Areas
Degrees
BS, Boston University
MS, Massachusetts Institute of Technology
PhD, Harvard-MIT Division of Health Sciences and Technology (HST)
Christina Silcox is the Research Director for Digital Health at the Duke-Margolis Center for Health Policy, working on policy solutions to advance innovation in health and health care and improve regulation, reimbursement, and long-term evaluation of medical products, with a focus on digital health.
Dr. Silcox’s portfolio includes multiple areas in digital health policy and real-world evidence, with an emphasis on medical devices. Currently, she is concentrating on challenges to regulating and adopting of artificial intelligence-enabled software as a medical device, using mHealth to collect real-world data, and characterizing real-world data quality and relevancy. Her projects have included the use of patient-generated health data in medical device evaluations, the exploration of value-based payments for medical devices, and the convening the National Evaluation System for health Technology (NEST) Planning Board.
Before she joined Duke-Margolis, Dr. Silcox was a senior fellow at the National Center for Health Research, focused on federal regulation of and policies for medical products. She earned a M.S. from the Massachusetts Institute of Technology (MIT) in Electrical Engineering and a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology (HST).
White Paper
Risk Assessment and Testing Considerations for Reducing SARS-CoV-2 Transmission in Congregate Care Facilities
The Rockefeller Foundation, Duke-Margolis Center for Health Policy
2021
Read MoreWhite Paper
Risk Assessment and Testing Protocols for Reducing SARS-CoV-2 Transmission in K-12 Schools
Caitlin Rivers, Christina Silcox, Christina Potter, Michelle Franklin, Rebecca Ray, Mira Gill, and Mark McClellan
2020
Read MoreCase Study
Paying for Value: Improving Outcomes, Costs, and Access through a Condition-based Bundle Payment Model
Christina Silcox, Beena Bhuiyan Khan, Rebecca Ray, Aparna Higgins, Marianne Hamilton Lopez, Mark McClellan
2020
Read MoreWhite Paper
Trust, But Verify: Informational Challenges Surrounding AI-Enabled Clinical Decision Software
Christina Silcox, Isha Sharma, & Arti Rai.
2020
Read MoreWhite Paper
A National Decision Point: Effective Testing and Screening for Covid-19
Christina Silcox, David Anderson, Anna Zavodszky, Ethan Borre, Susan Dentzer, Mara G. Aspinall, Mark McClellan
2020
Read MoreWhite Paper
A Roadmap for Developing Study Endpoints in Real-World Settings
Kerra Mercon, Nirosha Mahendraratnam, Joy Eckert, Christina Silcox, Morgan Romine, Kathryn Lallinger, Adam Kroetsch, Huzyfa Fazili, Marta Wosińska, Mark McClellan
2020
Read MoreWhite Paper
From Development to Market: Understanding COVID-19 Testing and Its Challenges
Monika Schneider, Susan Dentzer, Sarah Sheehan, Karley Whelan, Christina Silcox, Marianne Hamilton Lopez, Marta Wosińska, Mark McClellan
2020
Read MoreWhite Paper
Legislative and Regulatory Steps for a National COVID-19 Testing Strategy
Mark McClellan, Caitlin Rivers, and Christina Silcox
2020
Read MoreWhite Paper
Determining Real-World Data’s Fitness for Use and the Role of Reliability
Nirosha Mahendraratnam, Christina Silcox, Kerra Mercon, Adam Kroetsch, Morgan Romine, Nicholas R. Harrison, Adam Aten, Rachel Sherman, Gregory Daniel, Mark McClellan
2019
Read MoreWhite Paper
Current State and Near-Term Priorities for AI-Enabled Diagnostic Support Software in Health Care
Gregory Daniel, Isha Sharma, Christina Silcox, M. Bennett Wright
2019
Read MoreWhite Paper
The National Evaluation System for Health Technology (NEST): Priorities for Effective Early Implementation
Gregory W. Daniel, Heather M. Colvin, Christina E. Silcox, Mark B. McClellan, Jonathan M. Bryan
2016
Read More
Decision support tools are valuable, but only if consumers understand them and if they are accurate.
— Charlene Wong, MD, MSHP